111 related articles for article (PubMed ID: 2576521)
1. A family with an apparent HLA-DR triplet: evidence for exchange of functional HLA-DR beta-genes between different haplotypes.
Tilanus MG; van Eggermond MC; Fei HM; Schreuder GM; Giphart MJ
Exp Clin Immunogenet; 1989; 6(2):162-8. PubMed ID: 2576521
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of a recombinant HLA-DR1/DR2 haplotype.
Bidwell JL; Bidwell EA; Dupont E; Andrien M; Bouillenne C; Klouda PT; Bradley BA
Hum Immunol; 1992 Apr; 33(4):289-93. PubMed ID: 1353488
[TBL] [Abstract][Full Text] [Related]
3. Molecular, serologic, and functional evidence for an apparent HLA-DR triplet.
Bontrop RE; Schreuder GM; Elferink DG; Mikulski MM; Geerse R; Giphart MJ
J Immunol; 1986 Jul; 137(1):211-6. PubMed ID: 3486913
[TBL] [Abstract][Full Text] [Related]
4. Serologic and molecular studies of two kindreds expressing recombinant HLA DR1/DR2 haplotypes.
Wisecarver J; Shepherd S; Beisel K; Rubocki R
Tissue Antigens; 1993 Mar; 41(3):148-54. PubMed ID: 7686308
[TBL] [Abstract][Full Text] [Related]
5. Evolution of the HLA-DR1 gene family. Structural and functional analysis of the new allele "DR-BON".
Coppin HL; Avoustin P; Fabron J; Huchenq A; Garnier JM; Thomsen M; De Preval C
J Immunol; 1990 Feb; 144(3):984-9. PubMed ID: 1688595
[TBL] [Abstract][Full Text] [Related]
6. Analysis of gene structure and antigen determinants of DR2 antigens using DR gene transfer into mouse L cells.
Kawai J; Ando A; Sato T; Nakatsuji T; Tsuji K; Inoko H
J Immunol; 1989 Jan; 142(1):312-7. PubMed ID: 2462589
[TBL] [Abstract][Full Text] [Related]
7. Insulin-dependent diabetes mellitus: HLA-DR and -DQ genotyping in three ethnic groups.
Kohonen-Corish MR; Serjeantson SW; Lee HK; Zimmet P
Dis Markers; 1987 Sep; 5(3):153-64. PubMed ID: 2901933
[TBL] [Abstract][Full Text] [Related]
8. Molecular mapping of class II polymorphisms in the human major histocompatibility complex. I. DR beta.
Bell JI; Denney D; MacMurray A; Foster L; Watling D; McDevitt HO
J Immunol; 1987 Jul; 139(2):562-73. PubMed ID: 2885373
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR restriction-fragment-length polymorphisms in narcolepsy.
Holloman JD; Bell JI; Kilduff TS; Dement WC; Guilleminault C; McDevitt HO
J Neurosci Res; 1987; 18(1):239-44. PubMed ID: 2890770
[TBL] [Abstract][Full Text] [Related]
10. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
Liu CP; Bach FH; Wu SK
J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
[TBL] [Abstract][Full Text] [Related]
11. The HLA-DRB6*0201 allele of a pseudogene commonly associated with HLA-DR2 specificities is present in an HLA-DRB1*0101-DRB5*0101 haplotype.
Fischer GF; Fae I; Pickl WF
Immunogenetics; 1993; 37(4):285-7. PubMed ID: 8093608
[No Abstract] [Full Text] [Related]
12. Apparent HLA DR triplet due to the coexpression of a DRB5-encoded molecule on a DR1 haplotype.
Gebuhrer L; Tiercy JM; Freidel AC; Labonne MP; Lambert J; Jeannet M; Betuel H
Hum Immunol; 1992 Jun; 34(2):91-8. PubMed ID: 1429037
[TBL] [Abstract][Full Text] [Related]
13. Definition of DRw10 specificity by restriction fragment length polymorphism.
Semana G; Bignon JD; Quillivic F; Cheneau ML; Herniou E; Muller JY; Genetet B; Fauchet R
Tissue Antigens; 1988 Sep; 32(3):113-20. PubMed ID: 2464202
[TBL] [Abstract][Full Text] [Related]
14. Molecular mapping class II polymorphisms in the human major histocompatibility complex. II. DQ beta.
MacMurray AJ; Bell JI; Denney D; Watling D; Foster LS; McDevitt HO
J Immunol; 1987 Jul; 139(2):574-86. PubMed ID: 2885374
[TBL] [Abstract][Full Text] [Related]
15. A novel HLA haplotype containing a DRB5 gene associated with the DRB1*0103 allele.
Perrier P; Leotard B; Henry MA
Tissue Antigens; 1993 Nov; 42(5):518-21. PubMed ID: 7908467
[TBL] [Abstract][Full Text] [Related]
16. Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype. A study at the serological and genomic level.
Wilner A; Steinman L; Lavie P; Peled R; Friedmann A; Brautbar C
Hum Immunol; 1988 Jan; 21(1):15-22. PubMed ID: 2896649
[TBL] [Abstract][Full Text] [Related]
17. Lack of an association between diffuse systemic sclerosis and HLA-DR1 or HLA-DR5.
Kratz LE; Boughman JA; Needleman BW
Dis Markers; 1989; 7(4):209-13. PubMed ID: 2573446
[TBL] [Abstract][Full Text] [Related]
18. Definition of DRw10 by restriction fragment length polymorphism.
Lee S; Nuñez-Roldan A; Dwyer E; Pompeo L; Winchester R
Tissue Antigens; 1989 Apr; 33(4):466-74. PubMed ID: 2567539
[TBL] [Abstract][Full Text] [Related]
19. A division of HLA-DQw1 associated with DR1, DR1x-DQw1, DR2 short, DRw10, and DRw14. I. Definition by alloantiserum LY 1327.
Gebuhrer L; Betuel H; Lambert J; Freidel AC; Farre A
Hum Immunol; 1987 Mar; 18(3):235-45. PubMed ID: 2437088
[TBL] [Abstract][Full Text] [Related]
20. Limiting detection of an amplification signal for HLA-D region and VNTR genes by 32P-PCR.
McDaniel DO; Naftilan J; Barber WH
Biotechniques; 1993 Jul; 15(1):140-5. PubMed ID: 8363830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
